Conversely, another study showed that IGFBP-3 suppresses HCC cell proliferation via inhibition of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) expression (Ma et al., 2016). This evidence concerns the gene FGF2 and hepatocellular carcinoma.